Proportion of Drug-Intoxicated Organ Donors on the Rise in U.S.

Share this content:
Proportion of Drug-Intoxicated Organ Donors on the Rise in U.S.
Proportion of Drug-Intoxicated Organ Donors on the Rise in U.S.

FRIDAY, May 18, 2018 (HealthDay News) -- The drug abuse epidemic in the United States has been associated with an increase in the recovery of organs from brain-dead donors, according to a research letter published in the May 17 issue of the New England Journal of Medicine.

Mandeep R. Mehra, M.D., from Brigham and Women's Hospital in Boston, and colleagues analyzed data from a period of 17 years in the United States and Eurotransplant (a collective of transplantation centers in eight European countries) to examine the effect of drug-intoxication-related deaths on organ donation and outcomes.

The researchers observed a large increase in the proportion of organ donors who died from drug intoxication in the United States, from 1.2 percent in 2000 to 13.7 percent in 2016, which accounted for much of the increase in organ transplant activity in the last five years. No significant change over time was seen within Eurotransplant in terms of frequency of drug intoxication as the cause of donor death or in the overall number of organ donors. There was no significant difference in survival after transplantation for recipients of organs from donors who died from drug intoxication or blunt head injury; results were similar for comparisons involving other causes of death.

"The U.S. data indicate that survival among recipients of allografts from donors who died from drug intoxication is similar to survival among recipients from donors who died from other causes," the authors write.

Two authors disclosed financial ties to the pharmaceutical and medical device industries.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »